was conducted (EnVison+ System-HRP (DAB), DakoCytomation, Glostrup, Denmark) with

diaminobenzidine substrate, then counterstaining with hematoxylin. Positive stained cells were

counted from five randomly selected non-overlapping 200X fields.

Statistical analysis

Results of statistical analyses are expressed as means ± SEM. Differences among experimental

groups were confirmed by one-way ANOVA followed by Dunnett's test for individual

comparison of group means vs the control group. Survival analyses were compared by a log-

rank test. These calculations were performed with SigmaStat v3.10 (Systat Software Inc,

Richmond, CA). The null hypothesis was rejected when P < 0.05.NIH-PA Author Manuscript

NIH-PA Author Manuscript

NIH-PA Author ManuscriptSupplementary MaterialRefer to Web version on PubMed Central for supplementary material.AcknowledgementsWe thank Dr. Yan Qin for technical assistance.Disclosure This research was supported by the Intramural Research Program of the NIH, NIDDK. Thomas Jonassen,Jørgen Frøkiær, and Søren Nielsen have a financial interest in Action Pharma, which supplied no research funding,other than providing AP214.References1. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979through 2000. N Engl J Med 2003;348:1546–1554. [PubMed: 12700374]2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis.Jama 1996;275:1489–1494. [PubMed: 8622223]3. Neveu H, Kleinknecht D, Brivet F, et al. Prognostic factors in acute renal failure due to sepsis. Results

of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial

Transplant 1996;11:293–299. [PubMed: 8700363]

4. Russell JA, Singer J, Bernard GR, et al. Changing pattern of organ dysfunction in early human sepsis

is related to mortality. Crit Care Med 2000;28:3405–3411. [PubMed: 11057793]

5. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov

2005;4:854–865. [PubMed: 16224456]

6. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock--a review of laboratory models and

a proposal. J Surg Res 1980;29:189–201. [PubMed: 6997619]

7. Miyaji T, Hu X, Yuen PS, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple

organ damage in aged mice. Kidney Int 2003;64:1620–1631. [PubMed: 14531793]

8. Yasuda H, Yuen PS, Hu X, et al. Simvastatin improves sepsis-induced mortality and acute kidney

injury via renal vascular effects. Kidney Int 2006;69:1535–1542. [PubMed: 16557230]

9. Dear JW, Kobayashi H, Jo SK, et al. Dendrimer-enhanced MRI as a diagnostic and prognostic

biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int 2005;67:2159–2167.

[PubMed: 15882259]

10. Dear JW, Yasuda H, Hu X, et al. Sepsis-induced organ failure is mediated by different pathways in

the kidney and liver: Acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney

Int 2006;69:832–836. [PubMed: 16518342]

11. Star RA, Rajora N, Huang J, et al. Evidence of autocrine modulation of macrophage nitric oxide

synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A 1995;92:8016–8020.

[PubMed: 7544012]

12. Kohda Y, Chiao H, Star RA. alpha-Melanocyte-stimulating hormone and acute renal failure. Curr

Opin Nephrol Hypertens 1998;7:413–417. [PubMed: 9690041]

13. Chiao H, Kohda Y, McLeroy P, et al. Alpha-melanocyte-stimulating hormone protects against renal

injury after ischemia in mice and rats. J Clin Invest 1997;99:1165–1172. [PubMed: 9077523]